• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Lack of BCL10 mRNA mutation in lymphold malignancies.

作者信息

Kawano Takeshi, Iwase Satsuki, Nakayama Ritsuko, Horiguchi-Yamada Junko, Kobayashi Masayuki, Yamada Hisashi

机构信息

Department of Molecular Genetics, Institute of DNA Medicine, Jikei University School of Medicine, Tokyo, Japan.

出版信息

Anticancer Res. 2002 Jan-Feb;22(1A):305-9.

PMID:12017308
Abstract

BACKGROUND

BCL10, a gene involved in the chromosomal translocation t(1;14)(p22;q32) found in mucosa-associated lymphoid tissue lymphoma (MALT lymphoma), has shown mutation in not only MALT lymphomas but also other lymphold tumors. However, the mutation rate remains controversial. One possible reason is variation in the source material (DNA or RNA), with most studies having been done using tumor DNA. Accordingly, we studied BCL10 mutations using tumor RNA.

MATERIALS AND METHODS

Fifty lymphoid malignancies (26 malignant lymphomas, 10 chronic lymphocytic leukemias and 14 acute lymphoblastic leukemias) were examined. Total RNA was extracted from the tumor cells and first-strand cDNA was subjected to single-strand conformation polymorphism and fragment length analysis. Then the results were confirmed by direct sequencing.

RESULTS

No mutations of the BCL10 gene were found in the 50 samples. There were four polymorphisms (3G to T, 24G to C, 485C to T and 638G to A). All samples showed at least one 24C allele.

CONCLUSION

The BCL10 mutations studied are rare events at the RNA level and may not be associated with the mechanism of tumorigenesis in most lymphoid tumors.

摘要

相似文献

1
Lack of BCL10 mRNA mutation in lymphold malignancies.
Anticancer Res. 2002 Jan-Feb;22(1A):305-9.
2
BCL10 in malignant lymphomas--an evaluation using fluorescence in situ hybridization.恶性淋巴瘤中的BCL10——荧光原位杂交评估
J Pathol. 2002 Jan;196(1):59-66. doi: 10.1002/path.1015.
3
Bcl10 expression, rearrangement and mutation in MALT lymphoma: correlation with expression of nuclear factor-kappaB.黏膜相关淋巴组织淋巴瘤中Bcl10的表达、重排及突变:与核因子-κB表达的相关性
Int J Oncol. 2001 Aug;19(2):283-9.
4
MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression.伴有t(14;18)(q32;q21)/IGH-MALT1的黏膜相关淋巴组织淋巴瘤的特征是细胞质MALT1和BCL10呈强表达。
J Pathol. 2005 Feb;205(3):293-301. doi: 10.1002/path.1715.
5
Lack of Bcl10 mutations in malignant cartilaginous tumors.
Int J Mol Med. 2002 Mar;9(3):217-9.
6
Infrequent somatic Fas mutations but no evidence of Bcl10 mutations or t(11;18) in primary cutaneous MALT-type lymphoma.原发性皮肤黏膜相关淋巴组织型淋巴瘤中少见体细胞Fas突变,但无Bcl10突变或t(11;18)的证据。
J Pathol. 2003 Sep;201(1):134-40. doi: 10.1002/path.1426.
7
Detection of point mutations of BCL10 gene in hepatocellular carcinoma tissues: report of 46 cases.
Hum Mutat. 2000 May;15(5):482-3. doi: 10.1002/(SICI)1098-1004(200005)15:5<482::AID-HUMU17>3.0.CO;2-Z.
8
BCL10 gene mutations rarely occur in lymphoid malignancies.
Leukemia. 2000 May;14(5):905-8. doi: 10.1038/sj.leu.2401747.
9
Lack of BCL10 mutations in multiple myeloma and plasma cell leukemia.多发性骨髓瘤和浆细胞白血病中缺乏BCL10突变。
Genes Chromosomes Cancer. 2001 Apr;30(4):402-6.
10
Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas.BCL10的核表达或核因子κB可预测早期、高级别胃黏膜相关淋巴组织淋巴瘤的非幽门螺杆菌依赖状态。
J Clin Oncol. 2004 Sep 1;22(17):3491-7. doi: 10.1200/JCO.2004.10.087.